CYP1B1 enhances the resistance of epithelial ovarian cancer cells to paclitaxel in vivo and in vitro

Publisher： Spandidos Publications

E-ISSN： 1791-244X|35|2|340-348

ISSN： 1107-3756

Source： International Journal of Molecular Medicine, Vol.35, Iss.2, 2015-01, pp. : 340-348

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Erratum‐ovarian cancer cells, not normal cells, are damaged by mirk/dyrk1b kinase inhibition

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 6, 2015-09 ,pp. : E13-E13

John Wiley & Sons Inc

Access to resources Recommend Favorite

BCG Priming of Dendritic Cells Enhances T Regulatory and Th1 Function and Suppresses Allergen-Induced Th2 Function in vitro and in vivo

By  

International Archives of Allergy and Immunology, Vol. 150, Iss. 3, 2009-06 ,pp. : 210-220

Karger

Access to resources Recommend Favorite

Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 1, 2015-07 ,pp. : 221-229

John Wiley & Sons Inc

Access to resources Recommend Favorite

Overexpression of Cyclin D1 Is Associated with Poor Survival in Epithelial Ovarian Cancer

By  

Oncology, Vol. 66, Iss. 4, 2004-06 ,pp. : 310-315

Karger

Access to resources Recommend Favorite

CAP1 is overexpressed in human epithelial ovarian cancer and promotes cell proliferation

By                    

International Journal of Molecular Medicine, Vol. 35, Iss. 4, 2015-01 ,pp. : 941-949

Spandidos Publications

Access to resources Recommend Favorite